BSE filing, NSE: UNIVPHOTO. Summary written from the filing by ALFA Finder's alert engine.
Universus Photo Imagings Ltd: key numbers
- Share price
- ₹403.15
- Market cap
- ₹441.3 Cr
- Revenue (annual)
- ₹18.78 Cr
- Net profit (annual)
- ₹-79.94 Cr
- P/E (TTM)
- -25.1×Sector 52.0×
- Promoter holding
- 74.55%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Universus Photo Imagings Ltd
All →Universus Photo Imagings Annual General Meeting
Universus Photo Imagings Limited held its 15th Annual General Meeting on September 30, 2026. The meeting covered financial statement adoption and director re-appointments.
Universus Photo Imagings Results Correction
Universus Photo Imagings replied to NSE's Reg 33 segment clarification for Q1 FY27, stating it operates in a single segment. No financial corrections or restatements were made.
Universus Photo Imagings Annual Report
Universus Photo Imagings Limited has filed its Annual Report and Notice of the 15th Annual General Meeting for the financial year 2025-26.
Universus Photo Imagings Annual General Meeting
The company scheduled its 15th Annual General Meeting for September 30, 2026, and appointed a scrutinizer for the voting process.
Universus Photo Imagings Management Change
Universus Photo Imagings Limited re-appointed Sanjeev Aggarwal as Non-Executive Independent Director for 60 months and Suresh Kumar as Internal Auditor for 12 months.
Universus Photo Imagings Q1 FY27 Results: Turns Profitable, Net Profit ₹45.3 Cr
Universus Photo Imagings Ltd reported revenue from operations of ₹5.5 Cr (+10.0% YoY) and net profit of ₹45.3 Cr for Q1 FY27.
- Key figure
- Net profit ₹45.3 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.